These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 6291163)
1. [Blood sugar control in diabetics with the insulin pump. Comparison with discontinuous injections]. Sudre Y; Abadie JC; Marechaud R; Rossi F; Gouet D; Queron B Sem Hop; 1982 Sep; 58(32):1801-4. PubMed ID: 6291163 [TBL] [Abstract][Full Text] [Related]
2. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump. Cohen AW; Liston RM; Mennuti MT; Gabbe SG J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835 [TBL] [Abstract][Full Text] [Related]
3. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes. Buysschaert M; Lejeune M; Lambert AE Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116 [TBL] [Abstract][Full Text] [Related]
4. Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. Rizza RA; Gerich JE; Haymond MW; Westland RE; Hall LD; Clemens AH; Service FJ N Engl J Med; 1980 Dec; 303(23):1313-8. PubMed ID: 7001229 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of unstable diabetes with a portable insulin-infusion pump (author's transl)]. Talaulicar M; Willms B Dtsch Med Wochenschr; 1982 Mar; 107(11):419-23. PubMed ID: 7037348 [TBL] [Abstract][Full Text] [Related]
6. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients]. Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034 [TBL] [Abstract][Full Text] [Related]
7. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]
8. Clinical experience in human diabetics with portable and implantable insulin minipumps. Mirouze J; Selam JL; Slingeneyer A; Chaptal PA; Hedon B; Mares P; Franetzki M; Prestele K; Millet P; Beraud JJ Life Support Syst; 1983; 1(1):39-49. PubMed ID: 6678370 [TBL] [Abstract][Full Text] [Related]
9. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of unstable diabetes by continuous subcutaneous infusion of insulin]. Capani F; Consoli A; Guagnano T; Vitacolonna E; Sensi S Boll Soc Ital Biol Sper; 1981 Jul; 57(13):1424-6. PubMed ID: 7284110 [TBL] [Abstract][Full Text] [Related]
11. Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections. Meneghini L; Sparrow-Bodenmiller J Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S109-14. PubMed ID: 20515298 [TBL] [Abstract][Full Text] [Related]
12. [Ambulatory treatment of diabetes in children by continuous subcutaneous infusion of insulin using a portable pump]. Bougnères PF; Landier F; Lemmel C; Golse B; Chaussain JL Arch Fr Pediatr; 1984 Jan; 41(1):27-33. PubMed ID: 6721650 [TBL] [Abstract][Full Text] [Related]
13. Comparison of porcine insulin and human insulin (Novo) using the glucose-controlled insulin infusion system, glucose-insulin dose-response curves, and the outpatient effectiveness of human insulin (Novo) in insulin-dependent diabetes. Charles MA; Szekeres A; Staten M; Worcester B; Walsh KM Diabetes Care; 1983; 6 Suppl 1():29-34. PubMed ID: 6343034 [TBL] [Abstract][Full Text] [Related]
14. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study. Berhe T; Postellon D; Wilson B; Stone R Pediatrics; 2006 Jun; 117(6):2132-7. PubMed ID: 16740857 [TBL] [Abstract][Full Text] [Related]
15. Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study. Nimri R; Weintrob N; Benzaquen H; Ofan R; Fayman G; Phillip M Pediatrics; 2006 Jun; 117(6):2126-31. PubMed ID: 16740856 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of ambulatory unstable diabetic patients by continuous subcutaneous infusion of insulin: preliminary results (author's transl)]. Lambert AE; Buysschaert M; Van Halle B Diabete Metab; 1979 Dec; 5(4):307-12. PubMed ID: 398299 [TBL] [Abstract][Full Text] [Related]
17. Continuous intravenous insulin therapy with a miniaturized open-loop system. Renner R; Hepp KD; Mehnert H; Franetzki M Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077 [TBL] [Abstract][Full Text] [Related]
18. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459 [TBL] [Abstract][Full Text] [Related]